Abstract
BACKGROUND: Infected wounds, including those resulting from blast and gunshot injuries as well as diabetic foot, are a significant medical concern due to the high risk of complications and the need for long-term care. Therefore, the search for effective and safe topical therapies remains relevant. We performed a comparative evaluation of the efficacy of selected combination antimicrobial drugs and an antiseptic in treating such wounds, analyzing their effects on tissue regeneration, microbial burden, and clinical outcomes. AIM: The work aimed to assess the efficacy and safety of dioxomethyltetrahydropyrimidine + lidocaine + ofloxacin, dioxomethyltetrahydropyrimidine + chloramphenicol, and povidone-iodine in the treatment of infected wounds of various etiologies. METHODS: A single-center, open-label, non-interventional, observational, randomized controlled study was conducted in 60 patients (40 with blast/gunshot injuries and 20 with diabetic foot). Three drug products were selected for comparison: dioxomethyltetrahydropyrimidine + lidocaine + ofloxacin (Oflomelid, Sintez, Russia); dioxomethyltetrahydropyrimidine + chloramphenicol (Levomecol, Nizhpharm, Russia); and povidone-iodine (Betadine, Egis, Hungary). Treatment involved daily wound care throughout the observation period. Treatment outcomes included changes in wound healing (area, depth, exudate volume), pain intensity, and microbiological and biochemical parameters. RESULTS: Dioxomethyltetrahydropyrimidine + lidocaine + ofloxacin was associated with significantly greater changes in wound healing: reduction in wound area (p 0.001) and depth (p = 0.008), and decreased exudate volume (72.7% of patients without exudate by visit 4). Pain reduction was also more pronounced in the dioxomethyltetrahydropyrimidine + lidocaine + ofloxacin group (p 0.001). All therapies effectively suppressed the growth of Staphylococcus aureus; however, combination antimicrobial drugs outperformed the antiseptic by approximately 20%. Laboratory parameters improved in all groups, with antistreptolysin-O levels decreasing more significantly in the dioxomethyltetrahydropyrimidine + lidocaine + ofloxacin group (p = 0.009). CONCLUSION: All evaluated therapies were effective and safe; however, dioxomethyltetrahydropyrimidine + lidocaine + ofloxacin demonstrated superior results for key outcomes: accelerated wound healing, reduced bacterial load, and improved subjective therapy assessments. This combination drug (antibiotic + regenerative agent + anesthetic) has the potential to become the treatment of choice for complex infected wounds, such as those caused by trauma or diabetic foot.

This publication has 7 references indexed in Scilit: